Efficacy and Safety of Ritalin?? LA???, a New, Once Daily, Extended-Release Dosage Form of Methylphenidate, in Children with Attention Deficit Hyperactivity Disorder

Attention Deficit ◽

Dosage Form ◽

Extended Release ◽

Efficacy And Safety ◽

Once Daily ◽

A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.05.021 ◽

2020 ◽

Vol 42 (8) ◽

pp. 1452-1466 ◽

Cited By ~ 2

Author(s):

Azmi Nasser ◽

Tesfaye Liranso ◽

Toyin Adewole ◽

Nicholas Fry ◽

Joseph T. Hull ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Controlled Trial ◽

Phase Iii ◽

School Age Children ◽

School Age ◽

Efficacy And Safety ◽

Once Daily ◽

Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules Administered Once Daily to Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2009.0007 ◽

2009 ◽

Vol 19 (4) ◽

pp. 351-361 ◽

Cited By ~ 12

Author(s):

Ann C. Childress ◽

Thomas Spencer ◽

Frank Lopez ◽

Ortrud Gerstner ◽

Anuradha Thulasiraman ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Once Daily ◽

4.23 PIVOTAL PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF HLD200, A NOVEL DELAYED-RELEASE AND EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE, IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.218 ◽

2016 ◽

Vol 55 (10) ◽

pp. S170

Author(s):

Valerie K. Arnold ◽

Norberto J. DeSousa ◽

Bev Incledon ◽

Floyd R. Sallee ◽

Timothy E. Wilens ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Phase 3 ◽

Pivotal Phase ◽

Release Formulation ◽

Extended Release Formulation ◽

Hyperactivity Disorder ◽

Delayed Release

Effect of methylphenidate formulation on attention deficit hyperactivity disorder (ADHD)-patients' adherence to medical treatment. A comparison of Medikinet retard® (extended-release [ER]) once daily and Medikinet® (immediate-release [IR]) twice daily in children and adolescents diagnosed with ADHD

http://isrctn.org/> ◽

10.1186/isrctn93724387 ◽

2012 ◽

Author(s):

Claudia Wachtarz

Keyword(s):

Medical Treatment ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Immediate Release ◽

Once Daily ◽

Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison

European Child & Adolescent Psychiatry ◽

10.1007/s00787-017-0962-6 ◽

2017 ◽

Vol 26 (8) ◽

pp. 875-897 ◽

Cited By ~ 13

Author(s):

Alain Joseph ◽

Rajeev Ayyagari ◽

Meng Xie ◽

Sean Cai ◽

Jipan Xie ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Mixed Treatment Comparison ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Hyperactivity Disorder ◽

Treatment Comparison ◽

Mixed Treatment

6.9 Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2017.09.354 ◽

2017 ◽

Vol 56 (10) ◽

pp. S278-S279

Author(s):

Ann Childress ◽

Sally Berry ◽

Antonio Pardo ◽

Heidi W. Belden

Keyword(s):

Pilot Study ◽

Attention Deficit ◽

Early Onset ◽

Extended Release ◽

Oral Suspension ◽

Efficacy And Safety ◽

Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: A 4-week, randomized, double-blind, placebo-controlled, parallel-group study

Clinical Therapeutics ◽

10.1016/j.clinthera.2006.02.011 ◽

2006 ◽

Vol 28 (2) ◽

pp. 266-279 ◽

Cited By ~ 64

Author(s):

Thomas J. Spencer ◽

Timothy E. Wilens ◽

Joseph Biederman ◽

Richard H. Weisler ◽

Stephanie C. Read ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Parallel Group Study ◽

Parallel Group ◽

Adolescent Patients

Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1097/01.chi.0000220847.41027.5d ◽

2006 ◽

Vol 45 (7) ◽

pp. 817-823 ◽

Cited By ~ 41

Author(s):

LAURENCE L. GREENHILL ◽

RAFAEL MUNIZ ◽

ROBERTA R. BALL ◽

ALAN LEVINE ◽

LINDA PESTREICH ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2016.0177 ◽

2017 ◽

Vol 27 (8) ◽

pp. 690-699 ◽

Cited By ~ 7

Author(s):

Sharon B. Wigal ◽

Ann Childress ◽

Sally A. Berry ◽

Heidi Belden ◽

Faith Walters ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Hyperactivity Disorder ◽

Extended Release Tablet ◽

Release Tablet

Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder

Biological Psychiatry ◽

10.1016/j.biopsych.2006.07.032 ◽

2007 ◽

Vol 61 (12) ◽

pp. 1380-1387 ◽

Cited By ~ 98

Author(s):

Thomas J. Spencer ◽

Lenard A. Adler ◽

James J. McGough ◽

Rafael Muniz ◽

Hai Jiang ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽